β-catenin-IN-4
β-catenin-IN-4 (Compound 39) is a β-catenin inhibitor with a Ki of 0.64 μM. β-catenin-IN-4 reduces the protein expression levels of cyclin D1 and c-Myc[1].
Product Specifications
CAS Number
[2353536-67-9]
UNSPSC
12352005
Target
CDK; c-Myc; β-catenin
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Stem Cell/Wnt
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/β-catenin-in-4.html
Purity
99.84
Solubility
DMSO : 150 mg/mL (ultrasonic)
Smiles
O=C(N[C@H](C(NC1=CC=C(C=C1)OC(F)(F)F)=O)CCC(O)=O)[C@@H](NC([C@@H](NC(C2=CC3=C(N2)C=CC(Cl)=C3)=O)CC4=CC=C5C=CC=CC5=C4)=O)CC(O)=O
Molecular Formula
C38H33ClF3N5O9
Molecular Weight
796.14
References & Citations
[1]McCoy MA, et al. Biophysical Survey of Small-Molecule β-Catenin Inhibitors: A Cautionary Tale. J Med Chem. 2022 May 26;65 (10) :7246-7261.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Browse additional items from our catalog
DLD (Dihydrolipoyl Dehydrogenase, Mitochondrial) BioAssayTM ELISA Kit (Rat) discontinued
DLD (Dihydrolipoyl Dehydrogenase, Mitochondrial) BioAssayTM ELISA Kit (Rat) discontinued
Prostaglandin E2 Receptor EP3 Subtype (PGE2 Receptor EP3 Subtype, PGE Receptor EP3 Subtype, PGE2-R, PTGER3, EP3, EP3e, EP3-I, EP3-II, EP3-III, EP3-IV, MGC27302, MGC141828, MGC141829, Prostanoid EP3 Receptor) discontinued. see E3364-24
CCDC144NL, CT (CCDC144NL, Putative coiled-coil domain-containing protein 144 N-terminal-like) (MaxLight 550)